Literature DB >> 10052913

In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.

R Kariyama, H Kumon, L Chow, M J Zervos, T Takata, M Tabata, J W Chow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10052913     DOI： 10.1093/oxfordjournals.jac.a020872

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food.

Authors:  S M Donabedian; L A Thal; E Hershberger; M B Perri; J W Chow; P Bartlett; R Jones; K Joyce; S Rossiter; K Gay; J Johnson; C Mackinson; E Debess; J Madden; F Angulo; M J Zervos
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.

Authors:  V Kak; S M Donabedian; M J Zervos; R Kariyama; H Kumon; J W Chow
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 3.  Management of multidrug-resistant enterococcal infections.

Authors:  C A Arias; G A Contreras; B E Murray
Journal:  Clin Microbiol Infect       Date:  2010-06       Impact factor: 8.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.